• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体作为抗菌剂的特性及效率测试

Characterization and Testing the Efficiency of Phage as an Antibacterial Agent.

作者信息

Kusradze Ia, Karumidze Natia, Rigvava Sophio, Dvalidze Teona, Katsitadze Malkhaz, Amiranashvili Irakli, Goderdzishvili Marina

机构信息

G. Eliava Institute of Bacteriophages, Microbiology and Virology Tbilisi, Georgia.

G. Eliava Institute of Bacteriophages, Microbiology and VirologyTbilisi, Georgia; Ivane Javakhishvili Tbilisi State UniversityTbilisi, Georgia.

出版信息

Front Microbiol. 2016 Oct 4;7:1590. doi: 10.3389/fmicb.2016.01590. eCollection 2016.

DOI:10.3389/fmicb.2016.01590
PMID:27757110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5047890/
Abstract

is a gram-negative, non-motile bacterium that, due to its multidrug resistance, has become a major nosocomial pathogen. The increasing number of multidrug resistant (MDR) strains has renewed interest in phage therapy. The aim of our study was to assess the effectiveness of phage administration in wound infections in an animal model to demonstrate phage therapy as non-toxic, safe and alternative antibacterial remedy. Using classical methods for the study of bacteriophage properties, we characterized phage as a dsDNA myovirus with a 90 kb genome size. Important characteristics of include a short latent period and large burst size, wide host range, resistance to chloroform and thermal and pH stability. In a rat wound model, phage application effectively decreased the number of bacteria isolated from the wounds of successfully treated animals. This study highlights the effectiveness of the phage therapy and provides further insight into treating infections caused by MDR strains using phage administration.

摘要

是一种革兰氏阴性、无运动性的细菌,由于其多重耐药性,已成为主要的医院病原体。多重耐药(MDR)菌株数量的增加重新引发了对噬菌体疗法的兴趣。我们研究的目的是评估在动物模型中噬菌体给药对伤口感染的有效性,以证明噬菌体疗法是无毒、安全的替代抗菌疗法。使用研究噬菌体特性的经典方法,我们将噬菌体鉴定为一种基因组大小为90 kb的双链DNA肌病毒。其重要特征包括潜伏期短、裂解量高、宿主范围广、对氯仿有抗性以及热稳定性和pH稳定性。在大鼠伤口模型中,噬菌体的应用有效地减少了从成功治疗动物伤口分离出的细菌数量。这项研究突出了噬菌体疗法的有效性,并为使用噬菌体给药治疗由多重耐药菌株引起的感染提供了进一步的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd94/5047890/c668c2b324b7/fmicb-07-01590-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd94/5047890/b18d3adc8d6d/fmicb-07-01590-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd94/5047890/ed56c5858e6a/fmicb-07-01590-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd94/5047890/9c1daca9cb14/fmicb-07-01590-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd94/5047890/c668c2b324b7/fmicb-07-01590-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd94/5047890/b18d3adc8d6d/fmicb-07-01590-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd94/5047890/ed56c5858e6a/fmicb-07-01590-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd94/5047890/9c1daca9cb14/fmicb-07-01590-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd94/5047890/c668c2b324b7/fmicb-07-01590-g004.jpg

相似文献

1
Characterization and Testing the Efficiency of Phage as an Antibacterial Agent.噬菌体作为抗菌剂的特性及效率测试
Front Microbiol. 2016 Oct 4;7:1590. doi: 10.3389/fmicb.2016.01590. eCollection 2016.
2
Isolation of a lytic bacteriophage against extensively drug-resistant Acinetobacter baumannii infections and its dramatic effect in rat model of burn infection.分离针对广泛耐药鲍曼不动杆菌感染的溶菌噬菌体及其在烧伤感染大鼠模型中的显著效果。
J Clin Lab Anal. 2022 Jul;36(7):e24497. doi: 10.1002/jcla.24497. Epub 2022 Jun 16.
3
Phage therapy for Acinetobacter baumannii infection.噬菌体疗法治疗鲍曼不动杆菌感染。
Prog Mol Biol Transl Sci. 2023;200:303-324. doi: 10.1016/bs.pmbts.2023.04.006. Epub 2023 Jun 27.
4
Functional Analysis and Antivirulence Properties of a New Depolymerase from a Myovirus That Infects Acinetobacter baumannii Capsule K45.一种新型溶细胞噬菌体衍生脱聚酶的功能分析及其抗毒力特性研究,该噬菌体感染鲍曼不动杆菌 K45 荚膜。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01163-18. Print 2019 Feb 15.
5
Efficacy of a phage cocktail in controlling phage resistance development in multidrug resistant Acinetobacter baumannii.噬菌体鸡尾酒控制多重耐药鲍曼不动杆菌噬菌体耐药性发展的疗效。
Virus Res. 2019 Oct 15;272:197734. doi: 10.1016/j.virusres.2019.197734. Epub 2019 Aug 26.
6
Genome characterization of the novel lytic phage vB_AbaAut_ChT04 and the antimicrobial activity of its lysin peptide against Acinetobacter baumannii isolates from different time periods.新型溶菌噬菌体 vB_AbaAut_ChT04 的基因组特征及其溶菌肽对不同时期鲍曼不动杆菌分离株的抗菌活性。
Arch Virol. 2023 Sep 3;168(9):238. doi: 10.1007/s00705-023-05862-y.
7
Isolation and Characterization of a Infecting Multidrug-Resistant in A549 Alveolar Epithelial Cells.一株多重耐药 感染 A549 肺泡上皮细胞的分离与鉴定。
Viruses. 2022 Nov 19;14(11):2561. doi: 10.3390/v14112561.
8
Ability of bacteriophage in resolving wound infection caused by multidrug-resistant Acinetobacter baumannii in uncontrolled diabetic rats.噬菌体对控制糖尿病大鼠伤口耐多药鲍曼不动杆菌感染的作用。
Microb Drug Resist. 2015 Apr;21(2):171-7. doi: 10.1089/mdr.2014.0120. Epub 2014 Nov 20.
9
Isolation, characterization, and effectiveness of bacteriophage Pɸ-Bw-Ab against XDR isolated from nosocomial burn wound infection.从医院烧伤创面感染中分离出的耐多药菌的噬菌体Pɸ-Bw-Ab的分离、特性鉴定及有效性研究
Iran J Basic Med Sci. 2021 Sep;24(9):1254-1263. doi: 10.22038/ijbms.2021.57772.12850.
10
Characterization of Virulent T4-Like Bacteriophages DLP1 and DLP2.DLP1 和 DLP2 毒力 T4 样噬菌体的特性。
Viruses. 2023 Mar 13;15(3):739. doi: 10.3390/v15030739.

引用本文的文献

1
Genomic characterization and pre-clinical evaluation of a new polyvalent lytic Loughborough phage.一种新型多价裂解性拉夫堡噬菌体的基因组特征分析与临床前评估
Appl Microbiol Biotechnol. 2025 Aug 2;109(1):177. doi: 10.1007/s00253-025-13559-2.
2
Insight into Bacteriophage Therapy for Bacterial Infections and Cancer.对噬菌体疗法治疗细菌感染和癌症的见解。
Mol Biotechnol. 2025 Jul 9. doi: 10.1007/s12033-025-01466-w.
3
In vitro, genomic characterization and pre-clinical evaluation of a new thermostable lytic Obolenskvirus phage formulated as a hydrogel against carbapenem-resistant Acinetobacter baumannii.

本文引用的文献

1
Acinetobacter baumannii: biology and drug resistance - role of carbapenemases.鲍曼不动杆菌:生物学特性与耐药性——碳青霉烯酶的作用
Folia Histochem Cytobiol. 2016;54(2):61-74. doi: 10.5603/FHC.a2016.0009. Epub 2016 Jun 8.
2
Spread of carbapenem-resistant international clones of Acinetobacter baumannii in Turkey and Azerbaijan: a collaborative study.土耳其和阿塞拜疆耐碳青霉烯类鲍曼不动杆菌国际克隆株的传播:一项合作研究。
Eur J Clin Microbiol Infect Dis. 2016 Sep;35(9):1463-8. doi: 10.1007/s10096-016-2685-x. Epub 2016 Jun 4.
3
Colistin-resistant Acinetobacter baumannii ventilator-associated pneumonia in a tertiary care hospital: an evolving threat.
体外实验中,一种新型热稳定裂解性奥博连斯克病毒噬菌体的基因组特征分析及临床前评估,该噬菌体被制成水凝胶用于对抗耐碳青霉烯鲍曼不动杆菌。
Sci Rep. 2025 May 17;15(1):17149. doi: 10.1038/s41598-025-99788-x.
4
Recent insights on phage therapy against multidrug-resistant Acinetobacter baumannii.噬菌体疗法治疗多重耐药鲍曼不动杆菌的最新见解
AMB Express. 2025 Mar 12;15(1):44. doi: 10.1186/s13568-025-01837-1.
5
Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens.无形的敌人:革兰氏阴性ESKAPE病原体中的多重耐药抗菌机制
Antibiotics (Basel). 2025 Jan 9;14(1):63. doi: 10.3390/antibiotics14010063.
6
Characterization of two Friunavirus phages and their inhibitory effects on biofilms of extremely drug resistant Acinetobacter baumannii in Dakar, Senegal.塞内加尔达喀尔地区两种弗里乌诺病毒噬菌体的特性及其对耐多药鲍曼不动杆菌生物膜的抑制作用。
BMC Microbiol. 2024 Nov 5;24(1):449. doi: 10.1186/s12866-024-03608-7.
7
Characterization of bacteriophage vB_AbaS_SA1 and its synergistic effects with antibiotics against clinical multidrug-resistant Acinetobacter baumannii isolates.噬菌体 vB_AbaS_SA1 的特性及其与抗生素联合对抗临床多重耐药鲍曼不动杆菌分离株的协同作用。
Pathog Dis. 2024 Feb 7;82. doi: 10.1093/femspd/ftae028.
8
Treatment of infections caused by carbapenem-resistant .治疗耐碳青霉烯类抗生素的感染。
Front Cell Infect Microbiol. 2024 Jul 18;14:1395260. doi: 10.3389/fcimb.2024.1395260. eCollection 2024.
9
A Novel and Effective Therapeutic Method for Treating Infection in .一种治疗……感染的新颖且有效的治疗方法。
Animals (Basel). 2024 Mar 19;14(6):957. doi: 10.3390/ani14060957.
10
Characterization of a  phage vB_AbaM-SHI and its inhibition effect on biofilms of .噬菌体制备及其对. 生物膜抑制效果的表征。
Front Cell Infect Microbiol. 2024 Mar 8;14:1351993. doi: 10.3389/fcimb.2024.1351993. eCollection 2024.
三级医院中耐黏菌素鲍曼不动杆菌所致呼吸机相关性肺炎:一种不断演变的威胁
J Hosp Infect. 2016 Sep;94(1):72-3. doi: 10.1016/j.jhin.2016.04.014. Epub 2016 May 6.
4
Risk factors for infection with colistin-resistant gram-negative microorganisms: a multicenter study.耐黏菌素革兰氏阴性微生物感染的危险因素:一项多中心研究。
Ann Saudi Med. 2016 May-Jun;36(3):216-22. doi: 10.5144/0256-4947.2016.216.
5
In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357.噬菌体作为一种潜在治疗剂在体内的应用,用于控制属于序列型357的产OXA-66样碳青霉烯酶鲍曼不动杆菌菌株
Appl Environ Microbiol. 2016 Jun 30;82(14):4200-4208. doi: 10.1128/AEM.00526-16. Print 2016 Jul 15.
6
Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia.用噬菌体进行鼻内治疗可使小鼠从鲍曼不动杆菌介导的肺炎中获救。
Future Microbiol. 2016 May;11:631-41. doi: 10.2217/fmb.16.11. Epub 2016 Feb 29.
7
Ability of bacteriophage in resolving wound infection caused by multidrug-resistant Acinetobacter baumannii in uncontrolled diabetic rats.噬菌体对控制糖尿病大鼠伤口耐多药鲍曼不动杆菌感染的作用。
Microb Drug Resist. 2015 Apr;21(2):171-7. doi: 10.1089/mdr.2014.0120. Epub 2014 Nov 20.
8
Comparative analysis of the biological and physical properties of Enterococcus faecalis bacteriophage vB_EfaS_GEC-EfS_3 and Streptococcus mitis bacteriophage vB_SmM_GEC-SmitisM_2.肠球菌噬菌体 vB_EfaS_GEC-EfS_3 和酿脓链球菌噬菌体 vB_SmM_GEC-SmitisM_2 的生物学和物理特性比较分析。
Can J Microbiol. 2013 Jan;59(1):18-21. doi: 10.1139/cjm-2012-0385. Epub 2012 Nov 6.
9
Isolation and characterisation of lytic bacteriophages of Klebsiella pneumoniae and Klebsiella oxytoca.肺炎克雷伯菌和产酸克雷伯菌裂解噬菌体的分离与鉴定。
Curr Microbiol. 2013 Mar;66(3):251-8. doi: 10.1007/s00284-012-0264-7. Epub 2012 Nov 11.
10
Isolation and characterization of wide host range lytic bacteriophage AP22 infecting Acinetobacter baumannii.分离并鉴定一株广泛宿主范围裂解性噬菌体 AP22 对鲍曼不动杆菌的感染性。
FEMS Microbiol Lett. 2012 Jul;332(1):40-6. doi: 10.1111/j.1574-6968.2012.02573.x. Epub 2012 May 8.